Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.04B |
| 2 |
Chevron
CVX
|
+$820M |
| 3 |
Shopify
SHOP
|
+$599M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$539M |
| 5 |
Meta Platforms (Facebook)
META
|
+$479M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$675M |
| 2 |
Tesla
TSLA
|
+$661M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$633M |
| 4 |
Verizon
VZ
|
+$533M |
| 5 |
Alphabet (Google) Class C
GOOG
|
+$377M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 19.41% |
| 2 | Technology | 16.8% |
| 3 | Consumer Staples | 11.12% |
| 4 | Consumer Discretionary | 10.11% |
| 5 | Financials | 8.74% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
1601
DELISTED
Verve Therapeutics
VERV
| $4.75M | 0.01% |
+311,200
| New | +$4.82M |
|
|
SYNH
1602
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $4.75M | 0.01% |
+66,300
| New | +$4.85M |
|
1603
SouthState Bank Corp
SSB
$10.8B
| $4.73M | 0.01% |
61,340
-5,800
| -9% | -$452K |
|
1604
Teck Resources
TECK
$31.3B
| $4.73M | 0.01% |
154,600
-455,976
| -75% | -$18M |
|
1605
Primis Financial Corp
FRST
$413M
| $4.73M | 0.01% |
346,813
-52,600
| -13% | -$706K |
|
1606
Par Pacific Holdings
PARR
$4.12B
| $4.72M | 0.01% |
302,900
+194,900
| +180% | +$3.07M |
|
1607
C&F Financial
CFFI
$288M
| $4.72M | 0.01% |
102,600
-1,400
| -1% | -$69.9K |
|
1608
iShares Latin America 40 ETF
ILF
$3.69B
| $4.71M | 0.01% |
208,978
+183,978
| +736% | +$4.9M |
|
|
ESGR
1609
DELISTED
Enstar Group
ESGR
| $4.71M | 0.01% |
22,000
+5,100
| +30% | +$1.19M |
|
1610
Atea Pharmaceuticals
AVIR
$406M
| $4.71M | 0.01% |
663,000
-502,000
| -43% | -$3.43M |
|
1611
Gencor Industries
GENC
$264M
| $4.7M | 0.01% |
462,488
-27,152
| -6% | -$274K |
|
1612
Brixmor Property Group
BRX
$9.21B
| $4.7M | 0.01% |
232,400
+133,200
| +134% | +$3.15M |
|
1613
State Street SPDR Portfolio Aggregate Bond ETF
SPAB
$9.95B
| $4.69M | 0.01% |
+178,000
| New | +$4.74M |
|
1614
AptarGroup
ATR
$8.43B
| $4.69M | 0.01% |
45,400
+40,400
| +808% | +$4.41M |
|
1615
Crawford & Co Class A
CRD.A
$632M
| $4.68M | 0.01% |
600,124
-28,992
| -5% | -$225K |
|
1616
Healthcare Services Group
HCSG
$1.45B
| $4.68M | 0.01% |
268,664
-382,600
| -59% | -$6.6M |
|
1617
US Physical Therapy
USPH
$1.24B
| $4.65M | 0.01% |
42,623
+11,389
| +36% | +$1.21M |
|
1618
Skywest
SKYW
$4.21B
| $4.65M | 0.01% |
218,968
-203,231
| -48% | -$5.34M |
|
1619
Donaldson
DCI
$11.1B
| $4.65M | 0.01% |
96,600
+28,200
| +41% | +$1.42M |
|
1620
Vanguard FTSE Europe ETF
VGK
$31.1B
| $4.64M | 0.01% |
+87,900
| New | +$5.1M |
|
1621
Baxter International
BAX
$14B
| $4.63M | 0.01% |
72,000
-1,362,000
| -95% | -$98.8M |
|
1622
Horace Mann Educators
HMN
$2.1B
| $4.62M | 0.01% |
120,400
+26,769
| +29% | +$1.04M |
|
1623
Schwab International Equity ETF
SCHF
$69.3B
| $4.62M | 0.01% |
+293,800
| New | +$5M |
|
|
DOOR
1624
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $4.62M | 0.01% |
+60,100
| New | +$4.94M |
|
1625
Algoma Steel
ASTL
$471M
| $4.62M | 0.01% |
513,993
+449,093
| +692% | +$4.31M |
|
Similar funds
Jim Simons's Q2 2022 Portfolio in Review
As of Q2 2022, Jim Simons held 4,738 positions worth $84.5B, down 0.87% from $85.2B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Jim Simons deployed $13.7B of net new capital in Q2 2022, opening 694 new positions and adding to 1,955 existing holdings. Its largest new stake was Microsoft: 3,820,133 shares worth $981M.
By sector, the portfolio is most concentrated in Healthcare at 19% of assets, up from 19% a quarter earlier, followed by Technology and Consumer Staples.
On the sell side, the largest reduction was Tesla, an estimated $661M trimmed.
- Jim Simons's largest Q2 2022 buy was Microsoft: 3,820,133 shares worth $981M.
- Jim Simons added most to Chevron in Q2 2022, an estimated $820M increase.
- Jim Simons's biggest Q2 2022 reduction was Tesla, cutting an estimated $661M.
- Jim Simons fully exited Amazon in Q2 2022, selling an estimated $675M.
- Jim Simons's ten largest holdings make up 11% of its $84.5B portfolio in Q2 2022.
- Jim Simons opened 694 new positions and closed 562 in Q2 2022.
- Jim Simons's portfolio value fell 0.87% quarter-over-quarter to $84.5B.
Based on Renaissance Technologies's 13F filing for Q2 2022, filed 12 Aug 2022.